Geoffrey B. Johnson

7.2k total citations · 2 hit papers
147 papers, 3.5k citations indexed

About

Geoffrey B. Johnson is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Geoffrey B. Johnson has authored 147 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Radiology, Nuclear Medicine and Imaging, 60 papers in Pulmonary and Respiratory Medicine and 24 papers in Epidemiology. Recurrent topics in Geoffrey B. Johnson's work include Radiopharmaceutical Chemistry and Applications (28 papers), Prostate Cancer Treatment and Research (28 papers) and Medical Imaging Techniques and Applications (21 papers). Geoffrey B. Johnson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Prostate Cancer Treatment and Research (28 papers) and Medical Imaging Techniques and Applications (21 papers). Geoffrey B. Johnson collaborates with scholars based in United States, Canada and Denmark. Geoffrey B. Johnson's co-authors include Jeffrey L. Platt, Gregory J. Brunn, Yuzo Kodaira, Stephen M. Broski, Patrick J. Peller, Christopher H. Hunt, A. Tuba Kendi, Þorvarður R. Hálfdánarson, Martha Grogan and Eric C. Ehman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Geoffrey B. Johnson

136 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4

2002 536 citations Geoffrey B. Johnson, Gregory J. Brunn et al. The Journal of Immunology profile →
Theranostics and artificial intelligence: new frontiers in personalized medicine

2024 52 citations Gokce Belge Bilgin, Brian J. Burkett et al. profile →

Peers

Countries citing papers authored by Geoffrey B. Johnson

Since Specialization

Citations

This map shows the geographic impact of Geoffrey B. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey B. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey B. Johnson more than expected).

Fields of papers citing papers by Geoffrey B. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey B. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey B. Johnson. The network helps show where Geoffrey B. Johnson may publish in the future.

Co-authorship network of co-authors of Geoffrey B. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey B. Johnson. A scholar is included among the top collaborators of Geoffrey B. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey B. Johnson. Geoffrey B. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour ^99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison 2025 ·Circulation Cardiovascular Imaging ·Gregorio Tersalvi, (unknown), (unknown), Christopher G. Scott, Jun Zhang, (unknown), Leandi Krüger, Carrie B. Hruska, Geoffrey B. Johnson, Hayan Jouni, Martin Rodriguez‐Porcel, J. Wells Askew, John P. Bois, Kathleen A. Young, Nandan S. Anavekar, Martha Grogan, Angela Dispenzieri, Panithaya Chareonthaitawee, (unknown), Omar F. AbouEzzeddine	0
2	EARLY ADVERSE EVENTS, EMERGENCY ROOM VISITS AND HOSPITALIZATIONS AFTER PSMA BASED RLT: A RETROSPECTIVE ANALYSIS FROM REAL WORLD THERANOSTICS PRACTICE 2024 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), Daniel S. Childs, Geoffrey B. Johnson, Matthew Thorpe, Eugene D. Kwon, A. Tuba Kendi	0
3	Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same? 2024 ·European Urology Open Science ·Mohamed E. Ahmed, Ahmed Mahmoud, (unknown), (unknown), (unknown), (unknown), Irbaz Bin Riaz, Daniel S. Childs, Jacob J. Orme, A. Tuba Kendi, Geoffrey B. Johnson, R. Jeffrey Karnes, Eugene D. Kwon, Jack R. Andrews	3
4	Neurologic Symptoms After¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience 2024 ·Journal of Nuclear Medicine ·Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, (unknown), (unknown), Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor, A. Tuba Kendi	0
5	Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy study 2024 ·Medicine ·(unknown), Trond Velde Bogsrud, Hossein Gharib, Mabel Ryder, Geoffrey B. Johnson, Jolanta M. Durski	2
6	A Prospective, Phase II Study of 177Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Kenneth W. Merrell, Derek R. Johnson, (unknown), Michael W. Ruff, (unknown), (unknown), Daniel H. Lachance, (unknown), Elizabeth Yan, Ufuk Şener, (unknown), (unknown), P. Brown, Nadia N. Laack, Geoffrey B. Johnson	4
7	Assessment of hematological toxicity in patients with advanced neuroendocrine tumors and extensive/innumerable bone metastases undergoing lutetium-177 DOTATATE treatment. 2024 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Ephraim E. Parent, Jason R. Young, Geoffrey B. Johnson, A. Tuba Kendi, Þorvarður R. Hálfdánarson, Jason S. Starr	0
8	Targeted Alpha-Particle Therapy: A Review of Current Trials 2023 ·International Journal of Molecular Sciences ·Albert Jang, A. Tuba Kendi, Geoffrey B. Johnson, Þorvarður R. Hálfdánarson, Oliver Sartor	55
9	Low PSA radiographic disease progression on C11‐choline PET 2023 ·SHILAP Revista de lepidopterología ·Ahmed Mahmoud, Mohamed E. Ahmed, A. Tuba Kendi, Matthew Thorpe, Geoffrey B. Johnson, Irbaz Bin Riaz, Jacob J. Orme, Eugene D. Kwon, Jack R. Andrews, Daniel S. Childs	1
10	Metastasis-Directed Therapy for Metachronous Lung Metastases in Prostate Cancer 2023 ·JU Open Plus ·Ahmed Mahmoud, Robert W. Gao, Mohamed E. Ahmed, Jacob J. Orme, (unknown), William S. Harmsen, Geoffrey B. Johnson, Stephen D. Cassivi, Eugene D. Kwon, Ryan Phillips, Jack R. Andrews, Daniel S. Childs	2
11	Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis 2023 ·The Prostate ·Ahmed Mahmoud, Daniel S. Childs, Mohamed E. Ahmed, A. Tuba Kendi, Geoffrey B. Johnson, Jacob J. Orme, Bradley J. Stish, Ryan Phillips, Sean S. Park, Brian J. Davis, Jack R. Andrews, Eugene D. Kwon	2
12	ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule 2023 ·Journal of the American College of Radiology ·(unknown), Travis S. Henry, Mark F. Berry, Geoffrey B. Johnson, Aine Marie Kelly, Jane P. Ko, (unknown), Elizabeth Lee, Fabien Maldonado, (unknown), Reginald F. Munden, Constantine A. Raptis, (unknown), Arlene Sirajuddin, William Small, Betty C. Tong, Carol C. Wu, Edwin F. Donnelly	5
13	Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Fabrice Lucien, (unknown), Jing Qian, Jacob J. Orme, Henan Zhang, (unknown), (unknown), Ishwor Thapa, E. Tryggestad, William S. Harmsen, (unknown), Hesham Ali, Val J. Lowe, Geoffrey B. Johnson, Eugene D. Kwon, Haidong Dong, Sean S. Park	13
14	Pulmonary nodules in patients with primary Sjögren's syndrome: Causes, clinico-radiologic features, and outcomes 2020 ·Respiratory Medicine ·Marta Casal Moura, Patrick J. Navin, Geoffrey B. Johnson, Thomas E. Hartman, Misbah Baqir, Eunhee S. Yi, Jay H. Ryu	3
15	Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy 2018 ·European Radiology ·Matthew Koslow, Jason R. Young, Eunhee S. Yi, Misbah Baqir, Paul A. Decker, Geoffrey B. Johnson, Jay H. Ryu	27
16	Biphenotypic hepatic tumors: imaging findings and review of literature 2015 ·Abdominal Imaging ·Michael Wells, Sudhakar K. Venkatesh, Vishal S. Chandan, Jeff L. Fidler, Joel G. Fletcher, Geoffrey B. Johnson, David M. Hough, Lewis R. Roberts	39
17	B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis 2014 ·European Respiratory Journal ·(unknown), Geoffrey B. Johnson, Fabien Maldonado, James P. Utz, Ulrich Specks, Tobias Peikert	1
18	Toll-like receptor-4 and allograft responses 2004 ·Transplantation ·Benjamin Samstein, Geoffrey B. Johnson, Jeffrey L. Platt	32
19	Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 4 2004 ·The Journal of Immunology ·Geoffrey B. Johnson, Gregory J. Brunn, Jeffrey L. Platt	204
20	Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4 breakdown → 2002 ·The Journal of Immunology ·Geoffrey B. Johnson, Gregory J. Brunn, Yuzo Kodaira, Jeffrey L. Platt	536

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact